Predictive Cancer Biomarkers

Cancer biomarkers have become an indispensable part of cancer patient care. With discovery efforts on-going, the next phase towards conversion will involve validation and verification of clinical value. This includes the steps needed to manage the new treatment model from treating clinical symptoms to targeting genomic pathways. Focus will be given to the use of circulating tumour material to follow patients peripherally, both with known metastatic disease and post-surgery. In these Molecular Biomarkers conferences a special importance is given to this field.

  • Identifying and prioritizing biomarkers
  • Circulating biomarkers
  • Patient stratification using NGS data
  • Challenges and solutions for NGS labs

Related Conference of Predictive Cancer Biomarkers

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Predictive Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in